At Ipsen, we’re dedicated to improving people’s lives and health outcomes. Our 5,700 employees around the world are committed to tackling areas of high unmet medical need to improve the quality of life of patients and caregivers.

Our medicines are registered in more than 115 countries worldwide and we have a direct commercial presence in over 30 countries.

Founded 1929, Ipsen has been a family-owned business for the past 90 years and is a publicly traded business. We have four global R&D hubs and four pharmaceutical development centers around the world, and we invested €405.6m in R&D in 2020 alone.

In 2020, total sales exceeded €2.5bn, with double digit growth of almost 13% in North America.

We are one of the world’s top 15 biopharmaceutical companies in terms of oncology sales.